Literature DB >> 7663826

The omnipotence of voices. II: The Beliefs About Voices Questionnaire (BAVQ).

P Chadwick1, M Birchwood.   

Abstract

BACKGROUND: We describe the development and psychometric investigation of the Beliefs About Voices Questionnaire (BAVQ), a self-report measure of how people understand and respond to their voices. The measure is unique in being driven by and gathering data essential to a cognitive formulation of voices.
METHOD: Sixty subjects with chronic hallucinatory voices took part.
RESULTS: Psychometric properties of the scales were established, including test-retest reliability (mean = 0.89), internal reliability (mean Cronbach's alpha = 0.85), and construct validity using factor analysis and the criterion group method.
CONCLUSIONS: The BAVQ was found to be easy to complete and the scale may aid clinical assessment of voices, not least because of the possible value of cognitive therapy as a treatment approach.

Entities:  

Mesh:

Year:  1995        PMID: 7663826     DOI: 10.1192/bjp.166.6.773

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  16 in total

Review 1.  Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations.

Authors:  Max Birchwood; Zaffer Iqbal; Rachel Upthegrove
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

2.  The multidimensional measurement of the positive symptoms of psychosis.

Authors:  Craig Steel; Philippa A Garety; Daniel Freeman; Ellen Craig; Elizabeth Kuipers; Paul Bebbington; David Fowler; Graham Dunn
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

3.  Assessing anomalous perceptual experiences in nonpsychiatric individuals and outpatients with psychosis in Taiwan: an investigation using the cardiff anomalous perceptions scale (CAPS).

Authors:  Yu-Chen Kao; Tzong-Shi Wang; Chien-Wen Lu; Yia-Ping Liu
Journal:  Psychiatr Q       Date:  2013-06

4.  Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis.

Authors:  Steffen Moritz; Jerome Favrod; Christina Andreou; Anthony P Morrison; Francesca Bohn; Ruth Veckenstedt; Peter Tonn; Anne Karow
Journal:  Schizophr Bull       Date:  2012-02-15       Impact factor: 9.306

Review 5.  Clinical and neurocognitive aspects of hallucinations in Alzheimer's disease.

Authors:  Mohamad El Haj; Jean Roche; Renaud Jardri; Dimitrios Kapogiannis; Karim Gallouj; Pascal Antoine
Journal:  Neurosci Biobehav Rev       Date:  2017-02-21       Impact factor: 8.989

6.  CHoice of Outcome In Cbt for psychosEs (CHOICE): the development of a new service user-led outcome measure of CBT for psychosis.

Authors:  Kathryn E Greenwood; Angela Sweeney; Sally Williams; Philippa Garety; Elizabeth Kuipers; Jan Scott; Emmanuelle Peters
Journal:  Schizophr Bull       Date:  2009-10-30       Impact factor: 9.306

7. 

Authors:  Clément Dondé; Frédéric Haesebaert; Emmanuel Poulet; Marine Mondino; Jérôme Brunelin
Journal:  Can J Psychiatry       Date:  2019-12-13       Impact factor: 4.356

8.  Overgeneral autobiographical memory bias in clinical and non-clinical voice hearers.

Authors:  Pamela Jacobsen; Emmanuelle Peters; Thomas Ward; Philippa A Garety; Mike Jackson; Paul Chadwick
Journal:  Psychol Med       Date:  2018-03-14       Impact factor: 7.723

9.  [Beliefs and distress related to hearing voices: the German version of the Beliefs About Voices Questionnaire-Revised (BAVQ-R)].

Authors:  Andrea Gmeiner; Jessica Aslan; Amy Gaglia; Tamara Rumpold; Beate Schrank; Stefanie Süßenbacher; Michaela Amering
Journal:  Neuropsychiatr       Date:  2018-09-28

10.  A multi-centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations.

Authors:  Max Birchwood; Emmanuelle Peters; Nicholas Tarrier; Graham Dunn; Shon Lewis; Til Wykes; Linda Davies; Helen Lester; Maria Michail
Journal:  BMC Psychiatry       Date:  2011-09-30       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.